TY - JOUR
T1 - Prevention of sudden cardiac death in the young
T2 - Developing a rational, reliable, and sustainable national health care resource. A report from the Cardiac Safety Research Consortium
AU - Idriss, Salim F.
AU - Berger, Stuart
AU - Harmon, Kimberly G.
AU - Kindman, Allen
AU - Kleiman, Robert
AU - Lopez-Anderson, Martha
AU - Molossi, Silvana
AU - Saarel, Tess (Elizabeth)
AU - Strnadova, Colette
AU - Todaro, Thomas
AU - Shinagawa, Kaori
AU - Morrow, Valarie
AU - Krucoff, Mitchell
AU - Vetter, Victoria
AU - Wright, Theressa J.
N1 - Publisher Copyright:
© 2017 Elsevier Inc.
PY - 2017/8
Y1 - 2017/8
N2 - This White Paper, prepared by members of the Cardiac Safety Research Consortium, discusses important issues regarding sudden cardiac death in the young (SCDY), a problem that does not discriminate by gender, race, ethnicity, education, socioeconomic level, or athletic status. The occurrence of SCDY has devastating impact on families and communities. Sudden cardiac death in the young is a matter of national and international public health, and its prevention has generated deep interest from multiple stakeholders, including families who have lost children, advocacy groups, academicians, regulators, and the medical industry. To promote scientific and clinical discussion of SCDY prevention and to germinate future initiatives to move this field forward, a Cardiac Safety Research Consortium–sponsored Think Tank was held on February 21, 2015 at the US Food and Drug Administration's White Oak facilities, Silver Spring, MD. The ultimate goal of the Think Tank was to spark initiatives that lead to the development of a rational, reliable, and sustainable national health care resource focused on SCDY prevention. This article provides a detailed summary of discussions at the Think Tank and descriptions of related multistakeholder initiatives now underway: it does not represent regulatory guidance.
AB - This White Paper, prepared by members of the Cardiac Safety Research Consortium, discusses important issues regarding sudden cardiac death in the young (SCDY), a problem that does not discriminate by gender, race, ethnicity, education, socioeconomic level, or athletic status. The occurrence of SCDY has devastating impact on families and communities. Sudden cardiac death in the young is a matter of national and international public health, and its prevention has generated deep interest from multiple stakeholders, including families who have lost children, advocacy groups, academicians, regulators, and the medical industry. To promote scientific and clinical discussion of SCDY prevention and to germinate future initiatives to move this field forward, a Cardiac Safety Research Consortium–sponsored Think Tank was held on February 21, 2015 at the US Food and Drug Administration's White Oak facilities, Silver Spring, MD. The ultimate goal of the Think Tank was to spark initiatives that lead to the development of a rational, reliable, and sustainable national health care resource focused on SCDY prevention. This article provides a detailed summary of discussions at the Think Tank and descriptions of related multistakeholder initiatives now underway: it does not represent regulatory guidance.
UR - http://www.scopus.com/inward/record.url?scp=85020886906&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85020886906&partnerID=8YFLogxK
U2 - 10.1016/j.ahj.2017.05.003
DO - 10.1016/j.ahj.2017.05.003
M3 - Review article
C2 - 28760206
AN - SCOPUS:85020886906
SN - 0002-8703
VL - 190
SP - 123
EP - 131
JO - American heart journal
JF - American heart journal
ER -